• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代米索硝唑。心肌细胞缺氧的代谢标志物。

Fluoromisonidazole. A metabolic marker of myocyte hypoxia.

作者信息

Martin G V, Cerqueira M D, Caldwell J H, Rasey J S, Embree L, Krohn K A

机构信息

Division of Cardiology, Seattle Veterans Administration Medical Center, WA 98108.

出版信息

Circ Res. 1990 Jul;67(1):240-4. doi: 10.1161/01.res.67.1.240.

DOI:10.1161/01.res.67.1.240
PMID:2364494
Abstract

Fluoromisonidazole is metabolically trapped in viable hypoxic cells in vitro. This property is the basis for the hypothesis that [18F]fluoromisonidazole can be used to detect hypoxic tissues noninvasively using positron emission tomography. To assess the potential usefulness of this compound as a marker for hypoxic myocardium, we measured the accumulation of [3H]fluoromisonidazole in isolated adult rat myocytes under normoxic, hypoxic (5,000 ppm O2), and anoxic conditions. Both anoxia and hypoxia caused a marked increase in [3H]fluoromisonidazole accumulation. Relative to uptake during normoxia, uptake during anoxia was increased by 8.4-fold at 60 minutes and 26.5-fold at 180 minutes (p less than 0.001). During hypoxia, uptake was increased by 4.4-fold at 60 minutes and by 15.3-fold at 180 minutes (p less than 0.0001) and occurred in the absence of significant cell injury as measured by release of creatine kinase and changes in cell morphology. Additional studies demonstrated a slow oxygen-insensitive efflux of fluoromisonidazole or labeled metabolite(s) from myocytes reincubated in drug-free medium. We conclude that fluoromisonidazole is avidly retained in hypoxic myocytes and thus may be suitable for noninvasive detection of hypoxic myocardium using positron emission tomography.

摘要

氟米索硝唑在体外可被代谢捕获于存活的缺氧细胞中。这一特性是下述假说的基础,即[18F]氟米索硝唑可用于通过正电子发射断层扫描无创检测缺氧组织。为评估该化合物作为缺氧心肌标志物的潜在实用性,我们在常氧、缺氧(5000 ppm O2)和无氧条件下,测量了[3H]氟米索硝唑在分离的成年大鼠心肌细胞中的蓄积情况。缺氧和无氧均导致[3H]氟米索硝唑蓄积显著增加。与常氧时的摄取相比,无氧时60分钟摄取增加了8.4倍,180分钟时增加了26.5倍(p<0.001)。在缺氧时,60分钟摄取增加了4.4倍,180分钟时增加了15.3倍(p<0.0001),且在通过肌酸激酶释放和细胞形态变化测量未出现明显细胞损伤的情况下发生。进一步研究表明,在无药物培养基中再孵育的心肌细胞中,氟米索硝唑或标记代谢物的氧不敏感外排缓慢。我们得出结论,氟米索硝唑可被缺氧心肌细胞大量保留,因此可能适用于通过正电子发射断层扫描无创检测缺氧心肌。

相似文献

1
Fluoromisonidazole. A metabolic marker of myocyte hypoxia.氟代米索硝唑。心肌细胞缺氧的代谢标志物。
Circ Res. 1990 Jul;67(1):240-4. doi: 10.1161/01.res.67.1.240.
2
Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.缺氧细胞标志物[3H]氟米索硝唑在缺血心肌中的结合增强。
J Nucl Med. 1989 Feb;30(2):194-201.
3
Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium.
J Nucl Med. 1989 Mar;30(3):351-8.
4
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.放射性标记的氟米索硝唑作为缺氧细胞探针的特性研究。
Radiat Res. 1987 Aug;111(2):292-304.
5
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium.使用氟-18氟米索硝唑和正电子发射断层扫描在体内描绘冠状动脉闭塞期间的心肌缺氧:一种识别濒危心肌的潜在方法。
J Am Coll Cardiol. 1990 Aug;16(2):477-85. doi: 10.1016/0735-1097(90)90606-p.
6
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):985-91. doi: 10.1016/0360-3016(89)90146-6.
7
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.氟代脱氧葡萄糖——肿瘤缺氧的标志物?与[18F]氟米索硝唑及氧分压极谱法在转移性头颈癌中的比较
Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1426-31. doi: 10.1007/s00259-006-0175-6. Epub 2006 Jul 14.
8
Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.使用氟-18-氟米索硝唑和正电子发射断层扫描技术对缺氧心肌进行无创检测。
J Nucl Med. 1992 Dec;33(12):2202-8.
9
Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole.通过缺氧标志物[18F]氟米索硝唑评估细胞缺氧在脓毒症中的作用。
Am J Physiol. 1991 Oct;261(4 Pt 2):R965-72. doi: 10.1152/ajpregu.1991.261.4.R965.
10
Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole.根据[3H]氟米索硝唑摄取数据测定多细胞球体中的放射生物学缺氧分数。
Radiat Res. 1995 Jan;141(1):28-36.

引用本文的文献

1
PET Imaging in Cardiac Sarcoidosis: A Narrative Review with Focus on Novel PET Tracers.心脏结节病的正电子发射断层显像(PET):聚焦新型PET示踪剂的叙述性综述
Pharmaceuticals (Basel). 2021 Dec 9;14(12):1286. doi: 10.3390/ph14121286.
2
Correlation of Tumor Hypoxia Metrics Derived from F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue.基于 F-氟代莫司他正电子发射断层扫描和光透明脑组织中吡莫硝唑荧光图像的肿瘤乏氧指标相关性。
Tomography. 2020 Dec;6(4):379-388. doi: 10.18383/j.tom.2020.00046.
3
Oxygen Sensing, Hypoxia Tracing and Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.
用于非传染性疾病早期检测的功能性金属探针的氧传感、缺氧追踪与成像
Front Chem. 2018 Feb 23;6:27. doi: 10.3389/fchem.2018.00027. eCollection 2018.
4
PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts.心脏缺氧的正电子发射断层显像(PET):直击缺氧痛点
Curr Cardiovasc Imaging Rep. 2018;11(3):7. doi: 10.1007/s12410-018-9447-3. Epub 2018 Feb 23.
5
Molecular mechanisms of hypoxia in cancer.癌症中缺氧的分子机制
Clin Transl Imaging. 2017;5(3):225-253. doi: 10.1007/s40336-017-0231-1. Epub 2017 May 11.
6
Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.缺氧的分子成像:探针设计与应用策略
Curr Org Synth. 2011 Aug;8(4):593-603. doi: 10.2174/157017911796117179.
7
PET imaging of cardiac hypoxia: opportunities and challenges.正电子发射断层扫描(PET)成像在心肌缺氧中的应用:机遇与挑战。
J Mol Cell Cardiol. 2011 Nov;51(5):640-50. doi: 10.1016/j.yjmcc.2011.07.005. Epub 2011 Jul 14.
8
Novel imaging approaches to head and neck cancer.头颈部癌症的新型成像方法。
Semin Oncol. 2008 Jun;35(3):262-73. doi: 10.1053/j.seminoncol.2008.03.001.
9
Tracer kinetic modeling in nuclear cardiology.核心脏病学中的示踪剂动力学建模。
J Nucl Cardiol. 2000 Nov-Dec;7(6):686-700. doi: 10.1067/mnc.2000.111127.
10
Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion.
J Nucl Cardiol. 1998 May-Jun;5(3):285-94. doi: 10.1016/s1071-3581(98)90130-1.